Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs)
$105.03
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | GILD Avg Daily Volume: 17,560,700
Last Update: 01/27/15 - 3:59 PM EST
Volume: 0
YTD Performance: 11.43%
Open: $0.00
Previous Close: $105.03
52 Week Range: $63.50 - $116.83
Oustanding Shares: 1,508,664,333
Market Cap: 161,593,036,708
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 12 12 12
Moderate Buy 2 2 2 2
Hold 3 3 3 2
Moderate Sell 1 1 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.65 1.61 1.47 1.38
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 18.99
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
18.99 18.90 26.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.71% 33.19% 331.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 10.80 0.18 0.06
Earnings for GILD:
EBITDA 4.87B
Revenue 11.20B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $2.36 $3.49 $7.80 $10.51
Number of Analysts 2 1 2 2
High Estimate $2.36 $3.49 $7.91 $11.88
Low Estimate $2.36 $3.49 $7.69 $9.13
Prior Year $0.52 $1.44 $1.92 $7.80
Growth Rate (Year over Year) 353.85% 142.36% 306.25% 34.68%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jan 26, 2015 | 3:58 PM EST

These are surefire indications of a bountiful tape.

updateJP Morgan Healthcare Conf.

Jan 13, 2015 | 6:41 AM EST

JPMorgan Healthcare Conference (Day 2 of 4) - 01/12/15 - 01/15/15 San Francisco, CA

By

Christopher Versace

 | Jan 12, 2015 | 9:59 AM EST

Watch the share count when looking at earnings.

By

Timothy Collins

 | Jan 8, 2015 | 10:09 AM EST
Do you need to pick one name?
By

Kate Stalter

 | Jan 6, 2015 | 12:00 PM EST

They are prone to being whipsawed by news.

By

Bret Jensen

 | Jan 6, 2015 | 10:30 AM EST

They offer a nice shelter for the headwinds now hitting equities.

By

James "Rev Shark" DePorre

 | Jan 5, 2015 | 4:45 PM EST

If the market gaps down in the morning, watch for the dip buyers.

By

Gary Dvorchak

 | Dec 31, 2014 | 1:25 PM EST

Did my portfolio pass muster?

By

Chris Laudani

 | Dec 30, 2014 | 11:00 AM EST

Its hepatitis C drug will dominate the market.

By

James "Rev Shark" DePorre

 | Dec 29, 2014 | 4:20 PM EST

Everyone's too busy talking about what might happen in 2015.

On day's high and +$1.24 on the day.

this stock is unnaturally strong --domestic with yield--but there is no option activity so...
Market recovering slightly from deep early losses, but indices still lower than where they...
S&P futures bounced inside our zone @ 2020.30-2011.10. The S&P futures are not sho...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.